Collaboration with EA? Let’s see how much well being they have after playing this war of mine.
Correlation with self reported well being could be applied to opiate use. Let’s try
> People have never used more prescription opiate medication and no stakeholders are worried that this activity might be bad. So far, research has not had adequate data to test whether these worries are justified and if policymakers should act to more heavily regulate opiates. We attempt to provide much-needed evidence with adequate data. Whereas previous research had to rely on self-reported opiate use, we collaborated with two drug companies, Purdue Pharma and Johnson and Johnson, to obtain user’s actual drug usage behavior. We surveyed users of Oxycodone and Dilaudid for their well-being, motivations, and need satisfaction during drugs and merged their responses with prescription data. Contrary to many fears that excessive drug prescribing will lead to addiction and poor mental health, we found a positive relation between drug use and affective well-being. Need satisfaction and motivations during use did not interact with high time but were instead independently related to well-being. Our results advance the field in two important ways. First, we show that collaborations with industry partners can be done to high academic standards in an ethical and transparent fashion. Second, we deliver much-needed evidence to policymakers on the link between drugs and mental health.
(Self reported surveys are not ever scientific I don’t know how they can say high standards and post this after)
> Another limiting factor on the confidence in our results is the low response rate observed in both of our surveys. It is possible that various selection effects might have led to unrepresentative estimates of well-being, drug usage, or their relationship. Increasing response rates, while at the same time ensuring samples’ representativeness, remains a challenge for future studies in this field.
Correlation with self reported well being could be applied to opiate use. Let’s try
> People have never used more prescription opiate medication and no stakeholders are worried that this activity might be bad. So far, research has not had adequate data to test whether these worries are justified and if policymakers should act to more heavily regulate opiates. We attempt to provide much-needed evidence with adequate data. Whereas previous research had to rely on self-reported opiate use, we collaborated with two drug companies, Purdue Pharma and Johnson and Johnson, to obtain user’s actual drug usage behavior. We surveyed users of Oxycodone and Dilaudid for their well-being, motivations, and need satisfaction during drugs and merged their responses with prescription data. Contrary to many fears that excessive drug prescribing will lead to addiction and poor mental health, we found a positive relation between drug use and affective well-being. Need satisfaction and motivations during use did not interact with high time but were instead independently related to well-being. Our results advance the field in two important ways. First, we show that collaborations with industry partners can be done to high academic standards in an ethical and transparent fashion. Second, we deliver much-needed evidence to policymakers on the link between drugs and mental health.
(Self reported surveys are not ever scientific I don’t know how they can say high standards and post this after)
> Another limiting factor on the confidence in our results is the low response rate observed in both of our surveys. It is possible that various selection effects might have led to unrepresentative estimates of well-being, drug usage, or their relationship. Increasing response rates, while at the same time ensuring samples’ representativeness, remains a challenge for future studies in this field.